December 15th, 2015

Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Biogen’s Tecfidera Time-Out Pays Off

[at Motley Fool] – A decision to put off the launch of Biogen’s (BIIB) highly anticipated launch of its MS drug Tecfidera in Europe appears to have paid off, thanks to expanded patent . . . → Read More: Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Biogen’s Tecfidera Time-Out Pays Off Similar posts: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Biogen wins protection for MS drug Tecfidera in Europe Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB) Boeing’s Double Top: Will the company continue to soar?

Biogen Idec Inc. (NASDAQ:BIIB) [at Motley Fool] – A decision to put off the launch of Biogen’s (BIIB) highly anticipated launch of its MS drug Tecfidera in Europe appears to have paid off, thanks to expanded patent protection.
Read more on this.

Biogen Idec Inc. … [visit site to read more]

Similar posts:
  1. Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Biogen wins protection for MS drug Tecfidera in Europe
  2. Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB)
  3. Boeing’s Double Top: Will the company continue to soar?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.